UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 81

Sortiert nach

TP53 Mutation Mapping in Advanced Non-Small Cell Lung Cancer: A Real-World Retrospective Cohort Study

Current oncology (Toronto), 2022-10, Vol.29 (10), p.7411-7419

2022

Link zum Volltext

Verfügbarkeit prüfen

STRN-ALK Fusion in Lung Adenocarcinoma with Brain Metastasis Responded Well to Ensartinib: A Case Report

Current oncology (Toronto), 2022-09, Vol.29 (10), p.6749-6753

2022

Link zum Volltext

Verfügbarkeit prüfen

2-Deoxyglucose Suppresses ERK Phosphorylation in LKB1 and Ras Wild-Type Non-Small Cell Lung Cancer Cells

PloS one, 2016-12, Vol.11 (12), p.e0168793

2016

Link zum Volltext

Verfügbarkeit prüfen

A case report of steroid-refractory bullous pemphigoid induced by immune checkpoint inhibitor therapy

Frontiers in immunology, 2023-01, Vol.13, p.1068978

2023

Link zum Volltext

Verfügbarkeit prüfen

Real-world validation of the chemotherapy-induced nausea and vomiting predictive model and its optimization for identifying high-risk Chinese patients

Chinese medical journal, 2023-06, Vol.136 (11), p.1370-1372

2023

Link zum Volltext

Verfügbarkeit prüfen

CDK4/6 inhibitor palbociclib overcomes acquired resistance to third‐generation EGFR inhibitor osimertinib in non‐small cell lung cancer (NSCLC)

Thoracic cancer, 2020-09, Vol.11 (9), p.2389-2397

2020

Link zum Volltext

Verfügbarkeit prüfen

CBX4 plays a bidirectional role in transcriptional regulation and lung adenocarcinoma progression

Cell death & disease, 2024-05, Vol.15 (5), p.378-13, Article 378

2024

Link zum Volltext

Verfügbarkeit prüfen

Initial Treatment of Aumolertinib in Combination with Bevacizumab for Advanced NSCLC with Primary EGFR T790M Mutation: A Report of Three Cases and Literature Review

Zhongguo fei ai za zhi, 2023-02, Vol.26 (2), p.158-164

2023

Link zum Volltext

Verfügbarkeit prüfen

Salermide up‐regulates death receptor 5 expression through the ATF4‐ATF3‐CHOP axis and leads to apoptosis in human cancer cells

Journal of cellular and molecular medicine, 2012-07, Vol.16 (7), p.1618-1628

2012

Link zum Volltext

Verfügbarkeit prüfen

Targeting the EMT transcription factor Snail overcomes resistance to osimertinib in EGFR‐mutant non‐small cell lung cancer

Thoracic cancer, 2021-06, Vol.12 (11), p.1708-1715

2021

Link zum Volltext

Verfügbarkeit prüfen

Gene Fusions as Acquired Resistance Mechanisms of EGFR-TKI

Zhongguo fei ai za zhi, 2020-05, Vol.23 (5), p.381-387

2020

Link zum Volltext

Verfügbarkeit prüfen

Immune Checkpoint Inhibitors Related Diabetes Mellitus:  A Report of 2 Cases and Literature Review

Zhongguo fei ai za zhi, 2022-01, Vol.25 (1), p.61-65

2022

Link zum Volltext

Verfügbarkeit prüfen

Correlation Analysis between Neutrophil-to-lymphocyte Ratio  and the Risk of Malnutrition in Stage IV Primary Lung Cancer

Zhongguo fei ai za zhi, 2024-03, Vol.27 (3), p.193-198

2024

Link zum Volltext

Verfügbarkeit prüfen

Anlotinib plus icotinib as a potential treatment option for EGFR-mutated advanced non-squamous non-small cell lung cancer with concurrent mutations: final analysis of the prospective phase 2, multicenter ALTER-L004 study

Molecular cancer, 2023-08, Vol.22 (1), p.124-124, Article 124

2023

Link zum Volltext

Verfügbarkeit prüfen

Immunotherapy in Epidermal Growth Factor Receptor-mutant  Non-small Cell Lung Cancer

Zhongguo Fei Ai Za Zhi, 2019-08, Vol.22 (8), p.541-545

2019

Link zum Volltext

Verfügbarkeit prüfen

Clinical Development of Immunotherapy for Small Cell Lung Cancer

Zhongguo fei ai za zhi, 2018-12, Vol.21 (12), p.918-923

2018

Link zum Volltext

Verfügbarkeit prüfen

Retrospective study of EGFR‐mutant lung adenocarcinoma with bone metastatic clinical features

Cancer reports, 2023-01, Vol.6 (1), p.e1628-n/a

2023

Link zum Volltext

Verfügbarkeit prüfen

Research Progress of Klotho in Lung Neoplasms

Zhongguo fei ai za zhi, 2023-06, Vol.26 (6), p.473-478

2023

Link zum Volltext

Verfügbarkeit prüfen

Identification of a DNA damage repair gene‐related signature for lung squamous cell carcinoma prognosis

Thoracic cancer, 2022-04, Vol.13 (8), p.1143-1152

2022

Link zum Volltext

Verfügbarkeit prüfen

Research Progress of CDK4/6 Inhibitors in Non-small Cell Lung Cancer

Zhongguo fei ai za zhi, 2020-03, Vol.23 (3), p.176-181

2020

Link zum Volltext

Verfügbarkeit prüfen

The Glycolytic Inhibitor 2-Deoxyglucose Activates Multiple Prosurvival Pathways through IGF1R

The Journal of biological chemistry, 2009-08, Vol.284 (35), p.23225-23233

2009

Link zum Volltext

Verfügbarkeit prüfen

Research Progress of Immune Checkpoint Inhibitor Therapy for BRAF Mutation  in Non-small Cell Lung Cancer

Zhongguo Fei Ai Za Zhi, 2019-09, Vol.22 (9), p.583-589

2019

Link zum Volltext

Verfügbarkeit prüfen

EGFR exon 19‐deletion aberrantly regulate ERCC1 expression that may partly impaired DNA damage repair ability in non‐small cell lung cancer

Thoracic cancer, 2020-02, Vol.11 (2), p.277-285

2020

Link zum Volltext

Verfügbarkeit prüfen

Two Case Reports of Type 2 Diabetes Induced by Immune Checkpoint Inhibitors  Combined with Chemotherapy

Zhongguo fei ai za zhi, 2022-04, Vol.25 (4), p.287-290

2022

Link zum Volltext

Verfügbarkeit prüfen

Molecular mechanism of acquired drug resistance in the EGFR‐TKI resistant cell line HCC827‐TR

Thoracic cancer, 2020-05, Vol.11 (5), p.1129-1138

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 81

Suche als RSS-Feed

Aktive Filter

ThemaHumans

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(78)
Mit Volltextzugriff
(78)

Publikationsform

Artikel
(81)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(42)
Life Sciences & Biomedicine
(40)
Lung Cancer
(35)
Lung Neoplasms - Genetics
(31)
Oncology
(31)
Lung Neoplasms
(30)
Mutation
(29)
Lung Neoplasms - Pathology
(28)
Female
(23)
Lung Neoplasms - Drug Therapy
(23)
Carcinoma, Non-Small-Cell Lung - Genetics
(19)
Carcinoma, Non-Small-Cell Lung - Pathology
(19)
Aged
(18)
Male
(18)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(17)
Cancer Therapies
(16)
Kinases
(15)
Lung Neoplasms - Metabolism
(15)
Middle Aged
(15)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

TP53 Mutation Mapping in Advanced Non-Small Cell Lung Cancer: A Real-World Retrospective Cohort Study

STRN-ALK Fusion in Lung Adenocarcinoma with Brain Metastasis Responded Well to Ensartinib: A Case Report

2-Deoxyglucose Suppresses ERK Phosphorylation in LKB1 and Ras Wild-Type Non-Small Cell Lung Cancer Cells

A case report of steroid-refractory bullous pemphigoid induced by immune checkpoint inhibitor therapy

Real-world validation of the chemotherapy-induced nausea and vomiting predictive model and its optimization for identifying high-risk Chinese patients

CDK4/6 inhibitor palbociclib overcomes acquired resistance to third‐generation EGFR inhibitor osimertinib in non‐small cell lung cancer (NSCLC)

CBX4 plays a bidirectional role in transcriptional regulation and lung adenocarcinoma progression

Initial Treatment of Aumolertinib in Combination with Bevacizumab for Advanced NSCLC with Primary EGFR T790M Mutation: A Report of Three Cases and Literature Review

Salermide up‐regulates death receptor 5 expression through the ATF4‐ATF3‐CHOP axis and leads to apoptosis in human cancer cells

Targeting the EMT transcription factor Snail overcomes resistance to osimertinib in EGFR‐mutant non‐small cell lung cancer

Gene Fusions as Acquired Resistance Mechanisms of EGFR-TKI

Immune Checkpoint Inhibitors Related Diabetes Mellitus:  A Report of 2 Cases and Literature Review

Correlation Analysis between Neutrophil-to-lymphocyte Ratio  and the Risk of Malnutrition in Stage IV Primary Lung Cancer

Anlotinib plus icotinib as a potential treatment option for EGFR-mutated advanced non-squamous non-small cell lung cancer with concurrent mutations: final analysis of the prospective phase 2, multicenter ALTER-L004 study

Immunotherapy in Epidermal Growth Factor Receptor-mutant  Non-small Cell Lung Cancer

Clinical Development of Immunotherapy for Small Cell Lung Cancer

Retrospective study of EGFR‐mutant lung adenocarcinoma with bone metastatic clinical features

Research Progress of Klotho in Lung Neoplasms

Identification of a DNA damage repair gene‐related signature for lung squamous cell carcinoma prognosis

Research Progress of CDK4/6 Inhibitors in Non-small Cell Lung Cancer

The Glycolytic Inhibitor 2-Deoxyglucose Activates Multiple Prosurvival Pathways through IGF1R

Research Progress of Immune Checkpoint Inhibitor Therapy for BRAF Mutation  in Non-small Cell Lung Cancer

EGFR exon 19‐deletion aberrantly regulate ERCC1 expression that may partly impaired DNA damage repair ability in non‐small cell lung cancer

Two Case Reports of Type 2 Diabetes Induced by Immune Checkpoint Inhibitors  Combined with Chemotherapy

Molecular mechanism of acquired drug resistance in the EGFR‐TKI resistant cell line HCC827‐TR

Aktive Filter

Suchergebnisse filtern